Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sabine Schmoldt"'
Autor:
Matthias Wittwer, Peter Lasch, Alexander Indra, Daniela Jacob, Roland Grunow, Sabine Schmoldt, Michal Drevinek
Publikováno v:
Applied Biosafety. 17:59-63
In this article the authors describe the application of Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) Intact Cell Mass Spectrometry (ICMS) within a proficiency test organized by a European Union (EU)-funded project on the top
Autor:
Sabine Schmoldt, Thorsten Wendler, Jürgen Heesemann, Michael Hogardt, Ingrid Huber, Andreas Sing, Helmut Arbogast, Heidelore Söllner, Regina Schuhegger, Lutz Bader
Publikováno v:
Journal of Clinical Microbiology. 46:966-971
In recent years, clusters of Pneumocystis jirovecii (formerly Pneumocystis carinii ) pneumonia (PCP) among immunocompromised individuals have been reported. Mostly, the source of infections was suspected to be within the clinical settings when transp
Autor:
Jürgen Heesemann, Beate Balke, Michael Hogardt, Sebastian Suerbaum, Susanne Häuβler, Sabine Schmoldt
Publikováno v:
Journal of Cystic Fibrosis. 7:7-14
Background The goal of this pilot study was to design an external quality assessment (EQA) scheme for German cystic fibrosis (CF) clinical microbiology laboratories. Therefore, a multicentre study of 18 German CF laboratories was performed to evaluat
Autor:
Sabine Schmoldt, Jürgen Heesemann, Michael Hogardt, Lutz Bader, Christina Hoboth, Christine Henke
Publikováno v:
The Journal of Infectious Diseases. 195:70-80
Background. Pseudomonas aeruginosa (PA) strains with defective DNA mismatch repair genes generate numerous bacterial variants because of high mutation rates. In cystic fibrosis (CF), such mutator strains may lead to the rapid selection of survivors t
Autor:
Axel Imhof, Matthias Griese, Michael Hogardt, Juergen Heesemann, Sabine Schmoldt, Philipp Latzin
Publikováno v:
Journal of Medical Microbiology. 55:1425-1433
Inquilinus limosus is a novel Gram-negative bacterium of the subdivision α-Proteobacteria recently found in the airways of patients with cystic fibrosis (CF). Here, the authors report on the clinical courses of six CF patients colonized with I. limo
Autor:
Thomas Blankenstein, Stefan Bengsch, Anita Stumpf, Sabine Schmoldt, Harald Hoffmann, Jürgen Heesemann, Konrad Trülzsch, Andreas Roggenkamp
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 53:143-147
Enterobacter kobei is the species of the Enterobacter cloacae complex, which is phenotypically most closely related to the species E. cloacae. This is the first report of infection caused by a new biotype of E. kobei. A patient with a history of urin
Publikováno v:
Journal of Antimicrobial Chemotherapy. 54:1057-1061
OBJECTIVES AND METHODS With their potent activity against Gram-negative bacteria, the polymyxins are important alternative antibiotics for cystic fibrosis (CF) patients. A retrospective evaluation of polymyxin activity against 6001 Pseudomonas aerugi
Autor:
Siegbert Rieg, Sabine Schmoldt, Christian Theilacker, Katja de With, Silke Wölfel, Winfried V Kern, Gerhard Dobler
Publikováno v:
BMC Infectious Diseases, Vol 11, Iss 1, p 167 (2011)
BMC Infectious Diseases
BMC Infectious Diseases
Background Tick-borne lymphadenopathy (TIBOLA) was first described in 1997 in a patient in France. The causative agent, Rickettsia slovaca, is transmitted by Dermacentor ticks. Case presentation In southwestern Germany we encountered a patient with a
Autor:
Anja Eichner, Michael Hogardt, Axel Imhof, Christina Hoboth, Sabine Schmoldt, Christine Henke, Reinhard Hoffmann, Jürgen Heesemann
Background In patients with cystic fibrosis (CF), the emergence of hypermutable Pseudomonas aeruginosa drives the selection of P. aeruginosa variants that are efficiently adapted to the inflamed lungs of these patients. Objective To provide a detaile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73712102755262c80a7c7a3aa9d197f
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/78199
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/78199
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 25(1)
The determination of synergistic effects of antimicrobial drug combinations can lead to improved therapeutic options in the antibiotic treatment of cystic fibrosis patients who are chronically infected with multiresistant Pseudomonas aeruginosa isola